- The Healthtech Diaries
- Posts
- ⌚ Apple Watch: First FDA Approved Digital Health Tech
⌚ Apple Watch: First FDA Approved Digital Health Tech
The AFib feature of the Apple Watch has already been acknowledged for saving lives.
Jean Fernandes
May 03, 2024
Made with Leonardo AI.
💡 Spotlight
The trending stories of the week!
The FDA has granted approval to the Apple Watch for its atrial fibrillation (AFib) feature, permitting its utilization as a "biomarker test" in clinical studies aimed at assessing AFib burden and evaluating cardiac ablation devices. This milestone approval represents a significant advancement in digital health technology, augmenting the Apple Watch's role in medical research and clinical studies.
Innovaccer in Talks with Kaiser Permanente to Raise $250M 🚀
Healthtech startup Innovaccer is currently in discussions with Kaiser Permanente, a prominent health and insurance company in the United States, to secure a funding round ranging between $200 million to $250 million. This funding, a mix of primary and secondary capital, is expected to value Innovaccer at approximately $2.5 billion to $3 billion. The partnership between Kaiser Permanente and Innovaccer aims to enhance the quality of value-based care services.
Glen Tullman's health tech unicorn, Transcarent, secures $126M in funding 🦄
Glen Tullman, the former CEO of Livongo, has led his latest health tech startup Transcarent to secure $126 million in Series D funding. The investment, led by General Catalyst and 7wireVentures, values the company at $2.2 billion. Tullman plans to use the capital to advance Transcarent's artificial intelligence capabilities, fuel business growth, and pursue strategic acquisitions.
